VolitionRx Limited has successfully validated and verified the chemiluminescent immunoassay version of its Nu.Q Vet Cancer Test with Fujifilm Vet Systems Co. Ltd in Japan, enabling full automation in central laboratories through the IDS i10 automated analyzer platform. This transition from manual plates to automated processing is expected to support faster turnaround and higher throughput as demand grows, with more than 1,700 veterinary hospitals in Japan already registered to use the test.
The automation validation represents a significant step in addressing cancer detection for Japan's approximately seven million pet dogs. The automated platform aligns with the same system used for Volition's human Nu.Q Cancer, Nu.Q NETs and Nu.Q Discover products, underscoring cross-platform synergy between human and veterinary diagnostics. This technological consistency could streamline operations and potentially reduce costs across both medical sectors.
Volition is a multi-national company focused on advancing the science of epigenetics and is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help detect and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis.
The company's research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and an office in London. For further information, visit the company's website at https://volition.com/. The full press release can be viewed at https://ibn.fm/k076y.
Early detection and monitoring have the potential not only to prolong the life of patients, but also to improve their quality of life. The automation of the Nu.Q Vet Cancer Test in Japan represents a practical application of this principle in veterinary medicine, potentially making cancer screening more accessible and efficient for pet owners and veterinarians alike.
